Sign up to save your podcasts
Or
Share Episode 1: Surrogate Endpoints in AML
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 1: Surrogate Endpoints in AML
Bernie Marini and Anthony Perissinotti discuss the following paper on whether or not event-free survival (EFS) is an appropriate surrogate endpoint for overall survival (OS) in AML:
Norsworthy KJ, et al. Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses. J Clin Oncol. 2022 Mar 10;40(8):847-854. PMID: 34890212.
View all episodes
By Bernard Marini, Anthony Perissinotti, et al.
4.5
2828 ratings
Bernie Marini and Anthony Perissinotti discuss the following paper on whether or not event-free survival (EFS) is an appropriate surrogate endpoint for overall survival (OS) in AML:
Norsworthy KJ, et al. Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses. J Clin Oncol. 2022 Mar 10;40(8):847-854. PMID: 34890212.
More shows like WolverHeme Happy Hour
View all
The Hematologist
26 Listeners
JAMA Clinical Reviews
480 Listeners
OncoPharm
183 Listeners
VJHemOnc Podcast
3 Listeners
The Peter Attia Drive
7,765 Listeners
Plenary Session
745 Listeners
Treating Blood Cancers
13 Listeners
Blood Podcast
49 Listeners
Oncology Today with Dr Neil Love
54 Listeners
Healthcare Unfiltered
133 Listeners
EHA Unplugged
2 Listeners
Two Onc Docs
166 Listeners
Blood Cancer Talks
49 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
36 Listeners
HemeTalks: Conversations in Hematology Education
0 Listeners